II. Indications
- Severe Hyperbilirubinemia refractory to Phototherapy
- Hemolytic Disease of the Newborn
III. Indications: Exchange Transfusion for Hyperbilirubinemia in term infants (>36 weeks and >2 kg, or >35 weeks and >2.5 kg)
- See Severe Neonatal Hyperbilirubinemia Risk Factor
- Exchange Transfusion is indicated when a threshold is crossed based on an infants Hyperbilirubinemia risk factors
- High Risk Infant
- Gestational age >35 weeks AND <38 weeks AND Severe Neonatal Hyperbilirubinemia Risk Factor
- Intermediate Risk Infant
- Gestational age >38 weeks AND Severe Neonatal Hyperbilirubinemia Risk Factor OR
- Gestational age >35 weeks AND <38 weeks AND No Risk Factors
- Low Risk Infant
- Gestational age >38 weeks AND No Risk Factors
- High Risk Infant
- Age 0 hours of life
- High risk Infant: Serum Bilirubin >12 mg/dl
- Intermediate risk Infant: Serum Bilirubin >13.8 mg/dl
- Low risk Infant: Serum Bilirubin >16 mg/dl
- Age 12 hours of life
- High risk Infant: Serum Bilirubin >13.5 mg/dl
- Intermediate risk Infant: Serum Bilirubin >15.1 mg/dl
- Low risk Infant: Serum Bilirubin >17.6 mg/dl
- Age 24 hours of life
- High risk Infant: Serum Bilirubin >15 mg/dl
- Intermediate risk Infant: Serum Bilirubin >16.5 mg/dl
- Low risk Infant: Serum Bilirubin >19 mg/dl
- Age 36 hours of life
- High risk Infant: Serum Bilirubin >16 mg/dl
- Intermediate risk Infant: Serum Bilirubin >18 mg/dl
- Low risk Infant: Serum Bilirubin >20.9 mg/dl
- Age 48 hours of life
- High risk Infant: Serum Bilirubin >17 mg/dl
- Intermediate risk Infant: Serum Bilirubin >19.1 mg/dl
- Low risk Infant: Serum Bilirubin >22.2 mg/dl
- Age 60 hours of life
- High risk Infant: Serum Bilirubin >18 mg/dl
- Intermediate risk Infant: Serum Bilirubin >20.1 mg/dl
- Low risk Infant: Serum Bilirubin >23 mg/dl
- Age 72 hours of life
- High risk Infant: Serum Bilirubin >18.5 mg/dl
- Intermediate risk Infant: Serum Bilirubin >21.3 mg/dl
- Low risk Infant: Serum Bilirubin >23.9 mg/dl
- Age 84 hours of life
- High risk Infant: Serum Bilirubin >18.8 mg/dl
- Intermediate risk Infant: Serum Bilirubin >22 mg/dl
- Low risk Infant: Serum Bilirubin >24.4 mg/dl
- Age >96 hours of life (up to 7 days old or 168 hours)
- High risk Infant: Serum Bilirubin >19 mg/dl
- Intermediate risk Infant: Serum Bilirubin >22.5 mg/dl
- Low risk Infant: Serum Bilirubin >24.9 mg/dl
- References
- AAP: Management of Hyperbilirubinemia in Infant > 35 weeks
IV. Mechanism
- Extracts Antibody coated erythrocytes
- Extracts partially hemolyzed Red Blood Cells
- Replaces removed blood with uncoated donor RBCs
V. Technique
- Usually performed at neonatal tertiary centers
- Umbilical Venous Catheter placed at 7 cm or less
- Alternate aspiration and infusion
- Aspirate 20 cc of infant's blood
- Infuse 20 cc of donors blood
- Consider only 5-10 cc volumes in tenuous patients
- Exchange twice the infant's Blood Volume (2 x 85 ml/kg)
VI. Complications (5-10% of infants)
- Mortality: 0.3%
- Air Embolism
- Transient Vasospasm
- Transient Bradycardia
- Thrombocytopenia
- Transfusion Reaction
- Disseminated Intravascular Coagulation
- Electrolyte disturbance
- Sepsis
- Blood borne pathogen
- Cytomegalovirus
- HIV Infection
- Hepatitis
VII. Precautions
- Obtain lab work prior to exchange transfusion
- Lab findings on post-exchange blood are not helpful
- Pre-exchange blood sample labs
VIII. References
- Behrman (2000) Nelson Pediatrics, Saunders, p. 524
- (2000) Harriet Lane Handbook, Mosby, p. 431